Re' O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.
Curr Ther Res Clin Exp. 1974;16:1238 - 1242.
Knobel M. Approach to a combined pharmacologic therapy of childhood hyperkinesis.
Behav Neuropsychiatry. 1974 - 1975;6:87 - 90.
Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.
Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:233 - 239.
Kleijnen J, Knipschild P. Niacin and vitamin B
in mental functioning: a review of controlled trials in humans.
1991;29:931 - 941.
Carter CM, Urbanowicz M, Hemsley R, et al. Effects of a few food diet in attention deficit disorder.
Arch Dis Child. 1993;69:564 - 568.
Egger J, Carter CM, Graham PJ, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome.
Lancet. 1985;1:540 - 545.
Egger J, Stolla A, McEwen LM. Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome.
Lancet. 1992;339:1150 - 1153.
Rapp DJ. Does diet affect hyperactivity?
J Learn Disabil. 1978;11:383 - 389.
Rapp DJ. Food allergy treatment for hyperkinesis.
J Learn Disabil. 1979;12:608 - 616.
Rippere V. Food additives and hyperactive children: a critique of Conners.
Br J Clin Psychol. 1983;22:19 - 32.
Rippere V. Placebo-controlled tests of chemical food additives: are they valid?
Med Hypotheses. 1981;7:819 - 823.
Boris M, Mandel FS. Foods and additives are common causes of the attention deficit hyperactive disorder in children.
Ann Allergy. 1994;72:462 - 468.
Schoenthaler SJ, Crook WG, Brenner A, et al. Sugar and children's behavior [letters].
N Engl J Med. 1994;330:1901 - 1904.
Weiss B. Food additives and environmental chemicals as sources of childhood behavior disorders.
J Am Acad Child Psychiatry. 1982;21:144 - 152.
Weiss B, Williams JH, Margen S, et al. Behavioral responses to artificial food colors.
Science. 1980;207:1487 - 1489.
Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis.
JAMA. 1995;274:1617 - 1621.
Schmidt MH, Mocks P, Lay B, et al. Does oligoantigenic diet influence hyperactive/conduct-disordered children - a controlled trial.
Eur Child Adolesc Psychiatry.
1997;6:88 - 95.
Breakey J. The role of diet and behaviour in childhood.
J Paediatr Child Health.
1997;33:190 - 194.
Krummel DA, Seligson FH, Guthrie HA. Hyperactivity: is candy causal?
Crit Rev Food Sci Nutr.
1996;36:31 - 47.
Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
2001;139:189 - 196.
Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children.
J Abnorm Child Psychol.
1987;15:75 - 90.
Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine.
1989;25:222 - 228.
Van Oudheusden L, Scholte H. Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder.
Prostaglandins Leukot Essent Fatty Acids. 2002;67:33.
Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test.
Magnes Res. 1997;10:149 - 156.
Field TM, Quintino O, Hernandez-Reif M, et al. Adolescents with attention deficit hyperactivity disorder benefit from massage therapy.
26. Bilici M, Yildirim F, Kandil S et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:181-90.
27. Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry. 2004 Apr 8 [Epub ahead of print]
28. Arnold LE, Pinkham SM, Votolato N. Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivifty disorder? J Child Adolesc Psychopharmacol. 2000;10:111-117
29. Stevens L, Zhang W, Peck L et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003;38:1007-21.]